期刊
CURRENT OPINION IN VIROLOGY
卷 3, 期 5, 页码 495-500出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.coviro.2013.08.006
关键词
-
类别
资金
- National Health and Medical Research Council, Australia
Antiviral therapy for chronic hepatitis B (CHB) has improved the outcome of patients. However, due to the multiple selection pressures of different nucleos(t)ide analogue, drug resistant HBV variants have emerged. Because of the arrangement of overlapping reading frames in HBV genome, these variants not only have clinical implications such as drug resistance, but also the potential to pose public health issues via vaccine escape. Whilst emergence of these variants cannot be prevented, careful selection and institution of the appropriate rescue anti viral therapy based on high genetic barrier and high potency should minimize this outcome.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据